United States Veterinary Oncology Market, Forecast & Opportunities Report to 2029, Featuring Zoetis, Virbac, Ardent Animal Health, Varian Medical Systems, PetVet Care Centers and More
October 11, 2024 04:36 ET
|
Research and Markets
Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "United States Veterinary Oncology Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
U.S. Veterinary Oncology Market Report 2024-2030: Surgery, Radiology, Chemotherapy, Immunotherapy, Canine, Feline, Skin Cancer, Lymphoma, Sarcomas Size, Share & Trends Analysis
September 20, 2024 04:03 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Surgery, Radiology, Chemotherapy, Immunotherapy), By Animal...
Pet Cancer Therapeutics Market on the Rise: 2024 Research Report Shows Extensive Growth and Technological Advancements - Long-term Forecast to 2028 and 2033
January 30, 2024 10:44 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Pet Cancer Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global pet cancer therapeutics...
Veterinary Reference Laboratory Market Analysis 2023-2028 - Strategic Initiatives Drive Moderate Consolidation, with IDEXX Laboratories and Zoetis Inc. at the Helm
January 26, 2024 06:54 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Veterinary Reference Laboratory Market Size & Share Analysis - Growth Trends & Forecasts (2023-2028)" report has been added to ...
Veterinary Oncology Market Predicted to Garner $819.84 Million by 2030- Allied Market Research Report
October 26, 2021 09:59 ET
|
Allied Market Research
Portland, OR, Oct. 26, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global veterinary oncology market was accounted for $297.30 million in 2020, and is...
ImpriMed Launches New Diagnostic Services for Canine Lymphoma
October 19, 2021 08:00 ET
|
ImpriMed, Inc.
PALO ALTO, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- ImpriMed, Inc., a leading functional precision medicine company in veterinary oncology that provides a personalized drug response profiling...
Outlook on the Veterinary Oncology Global Market to 2025 - Competitive Analysis and the Impact of COVID-19
June 17, 2021 06:53 ET
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Global Veterinary Oncology Market (2020-2025) by Type, Animal Type, Therapy Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff...
Global Veterinary Oncology Industry (2020 to 2027) - Key Market Trends and Drivers
June 10, 2021 07:48 ET
|
Research and Markets
Dublin, June 10, 2021 (GLOBE NEWSWIRE) -- The "Veterinary Oncology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis,...
Oncology Pharma Extends Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Veterinary Oncology
February 22, 2021 08:00 ET
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, Feb. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma, Inc. (OTC: ONPH) is pleased to announce that it has extended a world-wide Licensing Agreement with NanoSmart...
Radiation Therapy for Pets: New Outcomes Data Presented by PetCure Oncology at Veterinary Cancer Society Annual Conference
October 22, 2019 11:05 ET
|
PetCure Oncology
Houston, TX, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Just a few weeks after celebrating the treatment of its 3,000th pet, national pet cancer care provider PetCure Oncology presented data suggesting that...